1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Tocilizumab for the treatment of systemic juvenile idiopathic arthritis

Technology appraisal guidance [TA238] Published date: 14 December 2011

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Related NICE guidance
  • 7 Review of guidance
  • Appendix A: Appraisal Committee members and NICE project team
  • Appendix B: Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download

Guidance

  • Next

6 Related NICE guidance

6 Related NICE guidance

  • Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis.NICE technology appraisal guidance 35 (2002).

  • National Institute for Health and Care Excellence (NICE)

  • Next